We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.50 | -2.17% | 67.50 | 65.00 | 70.00 | 69.00 | 67.30 | 69.00 | 2,236 | 08:46:38 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -5.14 | 15.91M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/6/2015 07:01 | I shall be expecting to see an all time closing high today, after what is a bullish pre AGM statement:- AGM Statement RNS RNS Number : 7804Q NetScientific PLC 22 June 2015 NetScientific plc Annual General Meeting London, UK - 22 June 2015 - NetScientific plc ("NetScientific" or "the Group", AIM: NSCI), the biomedical and healthcare technology group, is holding its Annual General Meeting (AGM) today at 11am. Ahead of this meeting Chairman, Sir Richard Sykes, will make the following comments: "2015 has been transformational for the Group's evolution. Notably, our Board review of the business strategy has led to a revitalised focus on funding, development and management of early and mid-stage healthcare technology companies, sourced from USA and UK strategic partnerships. We are concentrating on three core areas - proven technology in digital health, diagnostics and therapeutics. These sectors represent highly attractive growth markets where breakthrough technology solutions are in high demand. "The appointment of François Martelet as CEO in June was well timed for him to lead on the new strategy, bringing over 20 years' of biopharma experience and knowledge of commercialisation with him to further strengthen the team. François will be presenting at the AGM to highlight his next steps in the management of the Group including his plans to undergo an in-depth, systematic portfolio review in the three healthcare segments. He will stress his intention to accelerate growth in NetScientific's lead portfolio companies - Wanda, Vortex, Glucosense, Glycotest and Proaxsis and divest interests in non-core assets. A fuller update will follow with the interim results in September. "Today Nicholas Heckford, Executive Director - Commercial and Legal, has announced his retirement and departure from the Board at the end of September. Most of his responsibilities will be taken up by the Company Secretary, Ernest Schneider. Nicholas has been with the Group since inception and his contribution has been significant and much appreciated. We wish him all the best in his retirement." François Martelet's presentation will be available on Netscientific's website after the meeting. -Ends- About NetScientific NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.netscientific.ne | howdlep | |
19/6/2015 18:28 | In this video earlier today, Woodford highlights DDDD, ALM and OXP. All three have performed well today, perhaps on the back of this coverage. Quite possible that NSCI could be a short term beneficiary of this with Woodford in the press and investors searching for his next big winner. | protean | |
19/6/2015 18:19 | Woodford getting some positive press at the moment. He certainly has a consistent record over time as a fund manager. Of particular interest is his notable recent success in the biotech/pharma arena with the BBC article highlighting significant gains at DDDD and OXP. He'll be hoping the same success can be replicated here and is clearly confident of significant upside having taken a chunky 29% stake. | protean | |
19/6/2015 13:29 | Couldn't ignore this,so took a position albeit 2k.One decent contract then goodbye to 180s. | shafaq | |
19/6/2015 13:06 | Breakout, agm on Monday, two products into production this year, great management, small free float and many more pros | spurberry | |
19/6/2015 12:56 | here we go breakout now | 65jack | |
19/6/2015 09:57 | on the move now. breakout out underway | 65jack | |
19/6/2015 09:24 | AGM on Monday | pyglet | |
19/6/2015 07:45 | Close to breaking out here. can see a major breakout above £2 soon | 65jack | |
18/6/2015 10:48 | It is illiquid. That said, there's just been 11 trades in the last quarter hour. Plenty of interest. | mortimer7 | |
18/6/2015 10:37 | It's an illiquid stock so even tiny trades have an exaggerated influence on the price | mirabeau | |
18/6/2015 10:36 | if there is anything juicy normally a statement before markets open so 7am RNS hopefully. If not then AGM will be just ticking and voting and any RNS will not be price sensitive. Companies often use the agm day as a chance for a statement of some description if that is there is something good to be said. Gamble time maybe today and tomorrow to top up | angus17 | |
18/6/2015 10:32 | AGM Monday 22nd June 2015, 11am. Hope they issue an update statement afterwards. | mortimer7 | |
15/6/2015 10:10 | we were told contracts might be announced in June. Come on lets have some great news please. | angus17 | |
14/6/2015 15:47 | bamboo2, Its a free subscription, as is Twitter and his latest thoughts can be read here:- | howdlep | |
09/6/2015 08:42 | Near on 4% drop when only 2800 shares sold? Amazing! | pyglet | |
08/6/2015 07:18 | howdlep, it's a subscription site. What's his reputation like? | bamboo2 | |
08/6/2015 07:16 | Zak Mir out with 250p target while > 157p | howdlep | |
06/6/2015 16:18 | "In 2015, we anticipate commercial launches from our core portfolio companies, Wanda Health and Vortex BioSciences, further enhancing the value of our portfolio. Post year end, we initiated a review of our portfolio and strategy and we will report the results by mid-year 2015." Plenty of scope for newsflow and some in the near term. With such a small free float and the likes of Woodford in for the long haul, there is the potential for price to move very swiftly upwards on any positive RNS. | protean | |
06/6/2015 15:47 | Only 8.86% not held by the top 6 major shareholders!! | howdlep | |
06/6/2015 13:09 | I bet the free float is so tight here now. It's one of those stocks with deep, embedded (to be released) value. A tad similar to AMP but on a different scale | mirabeau | |
06/6/2015 11:24 | Thanks for your efforts protean and especially howdlep. I was planning to do the same thing. I doubt that Woodford will extend his holding now, unless there is a dilution. When he was with Invesco, it was very common for him to hold just under the 30% limit in various 'story' shares. Still great news though. | bamboo2 | |
06/6/2015 10:55 | Prior to yesterday's holding notifications, I have used Netscientific's AIM Rule 26 disclosure as of 3 March 2015 for the current positions. Please note, I am aware that the link kindly provided by protean is more accurate to two decimal places, but the holding notifications from yesterday are based on the prior percentage positions, as per Netscientifics AIM Rule 26 disclosure. OK prior to yesterday Name Amount of shares % Azima Family Trusts 17,152,020 47.8 (N.B The Azima Family Trusts combine Zahra Holding Ltd, White Mustard Investments Ltd and Cyrus Holdings) (N.B, White Mustard Investments Ltd formerly known as Quantadyne Limited) Zahra Holdings Ltd 11,795,000 32.9 Invesco Ltd 8,641,500 24.1 Woodford Investment Management 6,995,125 19.5 White Mustard Investments Ltd 3,430,000 9.6 Cyrus Holdings 1,927,020 5.4 Total 32,788,645 91.3 After yesterday's notifications Zahra Holdings Ltd 11,795,000 18.2 Invesco Ltd 8,641,500 24.1 Woodford Investment Management 6,995,125 29.4 White Mustard Investments Ltd 3,430,000 8.8 Cyrus Holdings 1,927,020 3.4 J O Hambro 2,600,000 7.24 Total 32,788,645 91.14 So the amoumt of shares in the hands of 3%+ major shareholders is relatively unchanged (using 1 decimal place creates a slight variance). HOWEVER the key thing here is that shares have been transferred from The Azima Family Trusts to Woodford Investment Management and to a new player, J O Hambro. Critically, Woodford Invstment Management are now just short of a MANDATORY TAKEOVER of NSCI. However, Invesco Ltd or J O Hambro could acquire a 30% holding first. Who will make the next move to acquire control? The winner will be NSCI shareholders.... | howdlep | |
05/6/2015 22:49 | Major Shareholders listed here but not yet updated to take into account today's RNSes: | protean | |
05/6/2015 18:23 | Cyrus Holdings Limited sell 696,567 to hold 1,230,453 or 3.4% White Mustard Investments Ltd sell 250,000 to hold 3,180,000 or 8.80% Zahra Holdings Limited sell 5,253,433 to hold 6,541,567 or 18.2% From the first holdings rns, "This form should be read together with the forms of White Mustard Investments Limited and Zahra Holdings Limited, also completed on this date, which together with Cyrus Holdings Limited in total held 17,152,020 shares representing 47.8 per cent of the Company's issued share capital prior to this notification and now hold 10,952,000 shares representing 30.5% of the Company's issued capital." | bamboo2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions